MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$158,545K
Inventories, net
$152,863K
Accounts receivable, net
$124,069K
Short-term
available-for-sale investments
$79,879K
Prepaid expenses and
other current assets
$32,618K
Total current assets
$547,974K
Intangible assets, net
$368,100K
Fixed assets, net
$140,690K
Deferred tax assets
$123,854K
Right-of-use assets, net
$41,777K
Investments and other assets
$22,308K
Goodwill
$20,214K
Total assets
$1,264,917K
Total liabilities and
stockholders equity
$1,264,917K
Total stockholders
equity
$693,111K
Total liabilities
$571,806K
Accumulated deficit
-$199,322K
Treasury stock, at cost,
inclusive of excise tax and...
$176,565K
Additional paid-in capital
$1,064,623K
Long-term debt, net
$372,189K
Total current
liabilities
$120,590K
Lease liabilities
$36,176K
Other liabilities
$20,572K
Contingent consideration
$18,066K
Deferred tax liabilities
$4,213K
Accumulated other
comprehensive income
$4,327K
Common stock, par value
0.001 250,000,000...
$48K
Accrued expenses
$95,601K
Accounts payable
$15,150K
Lease liabilities
$9,839K
Back
Back
Balance Sheet
source: myfinsight.com
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)